Clinical trial
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
Opening soon · Not applicable · 1 countries · Registry ID NCT07276763
Opening soonNot applicableObservational
What this study is about
A retrospective observational study to explore the impact of discontinuing GLP-1 receptor agonists for two weeks prior to upper endoscopy on the risk of gastric retention
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
AgeNot listed to Not listed
SexAll
Healthy volunteersNot accepted
ConditionGastric Retention
Full registry criteria
Inclusion Criteria: * Undergoing elective upper endoscopy * Complete clinical information available, including endoscopy report, age, sex, BMI, history of diabetes, prior gastric surgery, and gastrointestinal symptom Exclusion Criteria: * Presence of upper gastrointestinal malignancy or obstruction * History of gastric surgery (including ESD, gastrectomy, gastric bypass, etc.) * Emergency endoscopy or non-elective procedures * Missing key clinical information
Treatments and study arms
No Intervention: Observational Cohort
Other
No Intervention: Observational Cohort
Primary outcomes
Proportion of gastric retentionImmediately at study initiation
Study locations
1 locations were listed when this page was built. The first 40 are shown.
Huadong hospital, Fudan university🇨🇳 Shanghai, Shanghai Municipality, China